| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537738 | Vaccine | 2016 | 6 Pages |
Abstract
Seroprevalence of antibodies to PV3 is associated with age, gender and place of residence, in addition to the number of tOPV doses received. Ensuring high coverage and monitoring of response are essential as long as oral vaccines are used in polio eradication.
Keywords
SIAPV3tOPVmedian tissue culture infective doseTCID50IPVPHCIQRCDCHSCMLROPVχ2standard deviationImmunogenicityMultilevel logistic regressionWorld Health OrganizationSeroprevalenceconfidence intervalinterquartile rangeCenters for Disease Control and Preventionodds ratioInfantsIndiaInactivated poliovirus vaccineoral poliovirus vaccinePoliovirusChi-squareWHO
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Saravanakumar Puthupalayam Kaliappan, Srinivasan Venugopal, Sidhartha Giri, Ira Praharaj, Arun S. Karthikeyan, Sudhir Babji, Jacob John, Jayaprakash Muliyil, Nicholas Grassly, Gagandeep Kang,